Clinical Trials Browser

Neoplasm Metastasis × sintilimab × Tumor-Agnostic × Clear all

NCT07455617 2026-03-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

Phase 1 Not yet recruiting

Neoplasm Metastasis

NCT04055792 2023-06-28

Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC

Phase 2 Completed

Neoplasm Metastasis

NCT04398927 2021-02-04

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Phase 2 Withdrawn

Neoplasm Metastasis